Top Back to top

LYM1: Rituximab Purging and/or Maintenance in Patients Undergoing Autologous Transplantation for Relapsed Follicular Lymphoma: A Prospective Randomized Trial From the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation

Lymphoma Working Party (LWP)
Study number:
Type of Stem Cell Treatment:
Non-Hodgkin’s Lymphoma (NHL)
Short title:
Primary objective:
Key inclusion criteria:
Principal investigator:
Ruth Pettengell